Sukjun Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.
Journal: PloS one
Published: June 17, 2025
Pathologist-Artificial Intelligence Concordance in HER2 Interpretation for Advanced Biliary Tract Cancer: Intraobserver, Interobserver, and Human-Artificial Intelligence Variability.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 01, 2025
Phase II Study of Nivolumab and Ipilimumab for Treatment of Metastatic/Recurrent Adenoid Cystic Carcinoma (ACC) of all Anatomic Sites of Origin and Other Malignant Salivary Gland Tumors.
Journal: Cancer medicine
Published: June 29, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
Journal: Journal for immunotherapy of cancer
Published: January 27, 2024
An artificial intelligence-powered PD-L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.
Journal: Histopathology
Published: December 08, 2023
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 25, 2023
Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis.
Journal: Endocrine-related cancer
Published: May 31, 2023
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer.
Journal: NPJ precision oncology
Published: May 08, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026